Skip to main content

MoneyWorks4Me

RBI restricts foreign investors from buying in Claris Lifesciences

25 May 2017 Evaluate

The Reserve Bank of India (RBI) has restricted the Foreign Institutional Investors (FIIs)/Foreign Portfolio Investors (FPIs) in Claris Lifesciences as the foreign investors have crossed the overall limit of 24% of paid-up capital of the company.

RBI monitors ceilings on FII/NRI/PIO investments in Indian companies on a daily basis.

Claris Lifesciences is a multi-business enterprise and the holding company of Claris Injectables, a wholly- owned subsidiary dealing in Speciality Injectables business and has a minority stake in Claris Otsuka.


Peers
Company Name CMP
Redington 359.55
Adani Enterprises 2733.00
Amrapali Industries 33.62
Maxgrow India 182.35
Rashi Peripheral 696.70
View more..